First Quarter Earnings Call Scheduled for May 11, 2020

AUSTIN, Texas, April 6, 2020 /PRNewswire/ — Luminex Corporation today announced 1st quarter 2020 revenues of just over $90 million, up approximately 10% over the 1st quarter of 2019 and approximately 8% above the top end of its previously communicated 1st quarter revenue guidance range of $82 to $84 million. Highlights include:

Molecular Diagnostics Revenue of approximately $45 million, up more than 25% vs. Q1 2019, driven by SARS-CoV-2 pandemic-related sales:

Non-automated assays of $19 million, up more than 15% vs. Q1 2019

Sample-to-answer business of approximately $26 million, up more than 50% vs. Q1 2019

Automated assays of $23 million, up more than 35% vs. Q1 2019

Record sample-to-answer system placements: approximately 120 systems were sold or contracted, the majority of which